ArticleFrontiers in immunology2025

Combining the DNA methylation markers of circulating tumor cells with immune infiltrating cells to assess recurrence and prognosis and to suggest a therapeutic strategy in stage III-IV colorectal cancer.

Juan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.